WuXi Biologics provides contract research, development, and manufacturing services for biologics, offering end-to-end solutions from discovery to commercialization.

WuXi Biologics (Cayman) Inc. provides end-to-end solutions and services for biologics discovery, development and manufacturing in the People's Republic of China, North America, Europe, and internationally. The company also engages in the provision of consultation services in relation to the biopharmaceutical technology, international sales contracting services, testing and development of testing technologies, sales and marketing services, and biologics clinical and manufacturing services; production and sale of medicals; vaccine CDMO and related business; and material supplier activities. WuXi Biologics (Cayman) Inc. has strategic partnership with ImmuneOncia Therapeutics, Legochem Biosciences Inc, Worg Pharma, OncoC4, and Exelixis Inc. The company was incorporated in 2014 and is headquartered in Wuxi, China.

2269

COM:WUXIBIOLOGICS

WuXi Biologics

Last Close

12.86

25/09 08:08

Market Cap

46.18B

Beta: -

Volume Today

262.30M

Avg: -

locale

market

industry

website

ipo date

peer of

competitor of

Metrics